retatrutide phase 2 results obesity nejm 2023 hits 28% weight loss in 3 Weight Regain after Stopping Obesity
Description
GLP-1 Drugs Linked to Reduced Risk of Depression and Bipolar Disorder According to a new study published in Translational Psychiatry , lifelong genetic activation of the glucagon-like peptide-1 receptor (GLP-1R) was linked with better mental well-being and significantly lower odds of major depressive disorder and bipolar disorder
They include: Advertisement Less common causes of gastroparesis include: Complications of gastroparesis can include: Chronic nausea and vomiting, or simply the loss of appetite, can lead to weight loss and malnutrition
We believe that health is not a one-size-fits-all destination, but a personalized journey that should be achieved through science, empathy, and a transparent approach
It's a hit
If a patient starts on semaglutide and plateaus, their physician can evaluate whether switching to tirzepatide makes sense
On a similar note, GLP-1R modulates the consumption of cocaine and the motivation to consume cocaine later in the addiction cycle
